Human Papillomavirus (HPV) Genotyping Detection Kit
Real-time PCR Assays
100 copies/rxn
Product Description

Human Papillomavirus (HPV) Genotyping Detection Kit

Human papillomavirus (HPV) is a sexually transmitted DNA virus that establishes infection in squamous epithelial cells in the human body. There are more than 200 types of HPV, which can be classified into high or low-risk types depending upon their oncogenic potentials. High-risk HP Vs also called oncogenic HP Vs, which have been confirmed to cause cancer, includes HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68. And some HP Vs are possibly carcinogenic to humans, like HPV26, 53, 66, 70, 73 and 82, that be classified as high-risk or probably high-risk HP Vs. Low-risk HP Vs can cause genital warts and low-grade changes in the cells, but rarely cause cancer, such as HPV6 and 11. High-risk HPV infection is a necessary for the development of cancers of the uterine cervix, which has been firmly established. Approximately 99.7% of cervical cancers are caused by high-risk HPV infection. Cervical cancer is the second-most frequent malignancy among women worldwide.

Intended Use

The AmoyDx® Human Papillomavirus (HPV) Genotyping Detection Kit a real-time PCR assay for qualitative detection of 19 high-risk HPV DNA (HPV 16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 70, 73, and 82) and two low-risk HPV DNA (HPV 6 and 11) in cervical exfoliated cells and urogenital tract secretion. The kit is intended to access the high risk HPV DNA and aid in cervical cancer screening, early diagnostics and treatment.

The kit is for research use only, and intended to be used by trained professionals in a laboratory environment.

Testing Procedure
Compatible Sample Types:Cervical exfoliated cells or Urogenital tract secretion
Compatible Real-time PCR Instrument
Rotor-Gene Q
Rotor-Gene 6000
ABI 7500
Bio-Rad CFX96
Stratagene Mx3000P™
Other Info.

To order, please contact

Product Name Type Size (test/kit) Storage
AmoyDx® HPV Genotyping Detection Kit Bulk 48 -20±5℃

1. Vošmik, M., et al. "HPV Status and Mutation Analysis Using Multiparallel Sequencing in Distal Oesophageal and Gastro-oesophageal Junction Adenocarcinomas." Folia biologica 64.2 (2018): 41-45.
2. Nikakhtar, Zahra, et al. "The efficacy of vaginal suppository based on myrtle in patients with cervicovaginal human papillomavirus infection: A randomized, double‐blind, placebo trial." Phytotherapy research 32.10 (2018): 2002-2008.
3. Laco, Jan, et al. "SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity." Pathology-Research and Practice 213.2 (2017): 133-142.
4. Biesaga, Beata, et al. "The prevalence of HPV infection in rectal cancer–Report from South–Central Poland (Cracow region)." Pathology-Research and Practice 215.9 (2019): 152513.
5. Hladíková, Kamila, et al. "Tumor-infiltrating B cells affect the progression of oropharyngeal squamous cell carcinoma via cell-to-cell interactions with CD8+ T cells." Journal for immunotherapy of cancer 7.1 (2019): 261.

* Required information
Manage your account info
Change your password